Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, Gorowara M, Yamada N, Yanai H, Mitarai S, Ishikawa N, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K.
Avihingsanon A, et al. Among authors: ishikawa n.
Antivir Ther. 2008;13(4):529-36.
Antivir Ther. 2008.
PMID: 18672531
Clinical Trial.